文献速递临床免疫临床微生物

三种SARS-CoV-2免疫测定、三种快速侧流试验及新型珠基亲和替代试验在人血清中检测SARS-CoV-2抗体的性能

Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum.
PubMed 文献 · J Clin Microbiol · 2021-07-19

基于63例COVID-19幸存者(症状出现后长达7个月)的样本和50份大流行前血清,以50%斑块减少中和试验(PRNT50)为金标准,比较了三种商业免疫测定和三种快速侧流试验检测SARS-CoV-2 IgA和IgG抗体的性能。

要点

  • 以PRNT50为金标准,七种血清学试验敏感性差异大(7.0%-98.3%)。
  • 七种试验特异性范围为86.0%-100.0%,仅一种免疫测定敏感性和特异性均>98%。

核心结论

  • 七种SARS-CoV-2抗体检测试验性能差异显著,仅一种商业免疫测定敏感性和特异性均大于98%。

研究设计与样本

  • 基于63例COVID-19幸存者(症状出现后长达7个月)的样本和50份大流行前血清样本,以PRNT50为金标准比较七种试验性能。

主要发现

  • 七种试验敏感性范围为7.0%至98.3%,特异性范围为86.0%至100.0%。
  • 仅一种商业免疫测定敏感性和特异性均大于98%。

关键数值与推荐

  • 敏感性范围7.0%-98.3%,特异性范围86.0%-100.0%,仅一种免疫测定敏感性和特异性均>98%。

临床怎么用

  • 选择SARS-CoV-2抗体检测方法时应关注其敏感性和特异性,优先考虑性能均大于98%的免疫测定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For the control of immunity in COVID-19 survivors and vaccinated subjects, there is an urgent need for reliable and rapid serological assays. Based on samples from 63 COVID-19 survivors up to 7 months after symptom onset, and on 50 serum samples taken before the beginning of the pandemic, we compared the performances of three commercial immunoassays for the detection of SARS-CoV-2 IgA and IgG antibodies (Euroimmun SARS-COV-2 IgA/IgG, Mikrogen recomWell SARS-CoV-2 IgA/IgG, and Serion ELISA agile SARS-CoV-2 IgA/IgG) and three rapid lateral flow (immunochromatographic) tests (Abbott PanBio COVID-19 IgG/IgM, Nadal COVID-19 IgG/IgM, and Cleartest Corona 2019-nCOV IgG/IgM) with a 50% plaque-reduction neutralization test (PRNT50) representing the gold standard. Fifty-seven out of 63 PCR-confirmed COVID-19 patients (90%) showed neutralizing antibodies. The sensitivity of the seven assays ranged from 7.0% to 98.3%, and the specificity ranged from 86.0% to 100.0%. Only one commercial immunoassay showed a sensitivity and specificity of greater than 98%.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Krone M, Gütling J, Wagener J, et al. Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum. J Clin Microbiol. 2021. PMID: 33962959. doi:10.1128/JCM.00319-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。